生物标志物 生物标志物
Stefania Pezzoli1, Alexis P Oddi1, Ganna Blazhenets1
1University of California, San Francisco, San Francisco, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
APOE4基因型增加了记忆护理患者的粉样蛋白阳性风险. 携带APOE4的携带者,特别是携带APOE3/4的女性,表现出更高的粉样蛋白负担,为个性化痴呆症预防和治疗提供信息.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 医疗成像医学成像
背景情况:
- 有限的现实世界数据存在于APOE基因型在记忆护理中的实用性.
- IDEAS研究评估了粉样PET对有认知障碍的医疗保险受益人的临床影响.
- ANGI研究分析了IDEAS参与者的DNA,以将遗传与粉样蛋白状况联系起来.
研究的目的:
- 评估APOE基因型在确定粉样蛋白状况和负担中的预测价值.
- 评估APOE在现实世界内存护理环境中的作用.
- 调查APOE基因型和粉样蛋白PET发现之间的关系.
主要方法:
- 包括来自ANGI和IDEAS的1637名医疗保险受益者,他们有认知障碍.
- 通过视觉读取和百分值来确定粉样蛋白PET阳性.
- 使用后勤回归和ANCOVA分析阳性几率和粉样蛋白负担 (Centiloids) 的差异,调整为共变量.
主要成果:
- 携带APOE4的携带者 (异胞体和同胞体) 的痴呆率更高,MMSE得分更低.
- APOE4基因型 (APOE2/4,APOE3/4,APOE4/4) 显示,粉样蛋白阳性概率的剂量依赖性增加.
- 与具有APOE3/3基因型的男性相比,具有APOE3/4基因型的女性的粉样蛋白阳性几率明显更高.
结论:
- APOE基因型是粉样蛋白阳性和在现实世界记忆护理中的负担的重要预测因素.
- 遗传风险分层,包括性别特异性因素,可以为个性化的痴呆症预防和治疗策略提供信息.
- 纳入遗传信息可能会在认知障碍管理中改善临床结果.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


